Table 1 Selected companies pursuing anti-CGRP mAbs for migraine

From: Migraine mAbs crowd into late-stage trials

Company

Product

Clinical stage

Eli Lilly

LY2951742

Phase 3

Alder Biopharmaceuticals

ALD403

Phase 2b

TEVA

TEV-48125

Phase 2b

Amgen

AMG 334

Phase 2

Back to article page